Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):799–809. doi: 10.1161/ATVBAHA.118.312328

Table 2:

Subject disposition and basic characteristics in the AB023 phase 1 trial

AB023 Placebo Total (%)
0.1 mg/kg 0.5 mg/kg 2.0 mg/kg 5.0 mg/kg
No. of subjects included 4 4 4 4 5 21 (100)
No. of subjects withdrawn 0 0 0 0 0 0
Sex (males)
  (females)		 1
3		 2
2		 3
1		 3
1		 3
2		 12 (57)
9 (43)
Age (years)
 Mean (SD)		 42.8 (4.3) 33.0 (9.8) 32.0 (11.0) 42.0 (2.2) 32.2 (7.1) 36.2 (8.4)
Weight (kg)
 Mean (SD)		 71.7 (17.6) 68.3 (10.1) 72.0 (13.4) 75.7 (9.7) 73.2 (11.6) 72.2 (11.6)
BMI (kg/m2)
 Mean (SD)		 27.4 (2.5) 24.2 (2.9) 24.5 (2.8) 25.6 (1.7) 25.6 (2.6) 25.5 (2.5)

Abbreviations: BMI: body mass index; SD: tandard deviation